Seroprevalence of IgG antibodies against tetanus toxoid among different age groups in Poland

Vaccination is the most effective and reliable strategy for preventing the morbidity of tetanus. The aim of the study is to investigate the seroprevalence of antibodies to tetanus toxoid among healthy persons across all age groups to determine the level of vaccine-induced immunity in the population,...

Full description

Saved in:
Bibliographic Details
Published inAnnals of Agricultural and Environmental Medicine Vol. 31; no. 3; pp. 329 - 333
Main Authors Śmietańska, Karolina, Rastawicki, Waldemar
Format Journal Article
LanguageEnglish
Published Poland 25.09.2024
Subjects
Online AccessGet full text
ISSN1232-1966
1898-2263
1898-2263
DOI10.26444/aaem/182987

Cover

Loading…
Abstract Vaccination is the most effective and reliable strategy for preventing the morbidity of tetanus. The aim of the study is to investigate the seroprevalence of antibodies to tetanus toxoid among healthy persons across all age groups to determine the level of vaccine-induced immunity in the population, and to identify which age group should be targeted for a booster dose. A total of 2,842 serum samples collected between 2010 - 2019 from individuals aged from 1 month - 97 years were investigated. Anti-tetanus IgG antibody concentrations (IU/ml) were measured by an enzyme-linked immunosorbent assay. In addition, the avidity of antibodies was determined using an in-house ELISA. The results showed that among the 2,842 individuals, 147 (5.2%) had anti-tetanus toxoid IgG antibody levels below 0.1 IU/ml and another 1,519 (53.4%) subjects showed only basic protection (0.1-1.0 IU/ml) and needed immediate booster. High levels of anti-tetanus toxoid IgG antibodies (>1.0 IU/ml) were found more often in young adults at the age 21-40 years (55.5%, GMT=1.15). Importantly, these antibodies also had the highest avidity. With age, the percentage of high positives decreased, as well as the geometric mean and avidity of antibodies, reaching the lowest level in subjects over 70 years of age (13.3%; GMT=0.19). Characteristically, a higher percentage of high positive results was observed in men (42.6%) than in women (34.3%). The study showed adequate immunity levels to tetanus amongst the Polish population, especially in children, adolescents, and young adults. However, those from older age groups should receive booster doses of the vaccine.
AbstractList Vaccination is the most effective and reliable strategy for preventing the morbidity of tetanus. The aim of the study is to investigate the seroprevalence of antibodies to tetanus toxoid among healthy persons across all age groups to determine the level of vaccine-induced immunity in the population, and to identify which age group should be targeted for a booster dose. A total of 2,842 serum samples collected between 2010 - 2019 from individuals aged from 1 month - 97 years were investigated. Anti-tetanus IgG antibody concentrations (IU/ml) were measured by an enzyme-linked immunosorbent assay. In addition, the avidity of antibodies was determined using an in-house ELISA. The results showed that among the 2,842 individuals, 147 (5.2%) had anti-tetanus toxoid IgG antibody levels below 0.1 IU/ml and another 1,519 (53.4%) subjects showed only basic protection (0.1-1.0 IU/ml) and needed immediate booster. High levels of anti-tetanus toxoid IgG antibodies (>1.0 IU/ml) were found more often in young adults at the age 21-40 years (55.5%, GMT=1.15). Importantly, these antibodies also had the highest avidity. With age, the percentage of high positives decreased, as well as the geometric mean and avidity of antibodies, reaching the lowest level in subjects over 70 years of age (13.3%; GMT=0.19). Characteristically, a higher percentage of high positive results was observed in men (42.6%) than in women (34.3%). The study showed adequate immunity levels to tetanus amongst the Polish population, especially in children, adolescents, and young adults. However, those from older age groups should receive booster doses of the vaccine.
Vaccination is the most effective and reliable strategy for preventing the morbidity of tetanus. The aim of the study is to investigate the seroprevalence of antibodies to tetanus toxoid among healthy persons across all age groups to determine the level of vaccine-induced immunity in the population, and to identify which age group should be targeted for a booster dose.INTRODUCTION AND OBJECTIVEVaccination is the most effective and reliable strategy for preventing the morbidity of tetanus. The aim of the study is to investigate the seroprevalence of antibodies to tetanus toxoid among healthy persons across all age groups to determine the level of vaccine-induced immunity in the population, and to identify which age group should be targeted for a booster dose.A total of 2,842 serum samples collected between 2010 - 2019 from individuals aged from 1 month - 97 years were investigated. Anti-tetanus IgG antibody concentrations (IU/ml) were measured by an enzyme-linked immunosorbent assay. In addition, the avidity of antibodies was determined using an in-house ELISA.MATERIAL AND METHODSA total of 2,842 serum samples collected between 2010 - 2019 from individuals aged from 1 month - 97 years were investigated. Anti-tetanus IgG antibody concentrations (IU/ml) were measured by an enzyme-linked immunosorbent assay. In addition, the avidity of antibodies was determined using an in-house ELISA.The results showed that among the 2,842 individuals, 147 (5.2%) had anti-tetanus toxoid IgG antibody levels below 0.1 IU/ml and another 1,519 (53.4%) subjects showed only basic protection (0.1-1.0 IU/ml) and needed immediate booster. High levels of anti-tetanus toxoid IgG antibodies (>1.0 IU/ml) were found more often in young adults at the age 21-40 years (55.5%, GMT=1.15). Importantly, these antibodies also had the highest avidity. With age, the percentage of high positives decreased, as well as the geometric mean and avidity of antibodies, reaching the lowest level in subjects over 70 years of age (13.3%; GMT=0.19). Characteristically, a higher percentage of high positive results was observed in men (42.6%) than in women (34.3%).RESULTSThe results showed that among the 2,842 individuals, 147 (5.2%) had anti-tetanus toxoid IgG antibody levels below 0.1 IU/ml and another 1,519 (53.4%) subjects showed only basic protection (0.1-1.0 IU/ml) and needed immediate booster. High levels of anti-tetanus toxoid IgG antibodies (>1.0 IU/ml) were found more often in young adults at the age 21-40 years (55.5%, GMT=1.15). Importantly, these antibodies also had the highest avidity. With age, the percentage of high positives decreased, as well as the geometric mean and avidity of antibodies, reaching the lowest level in subjects over 70 years of age (13.3%; GMT=0.19). Characteristically, a higher percentage of high positive results was observed in men (42.6%) than in women (34.3%).The study showed adequate immunity levels to tetanus amongst the Polish population, especially in children, adolescents, and young adults. However, those from older age groups should receive booster doses of the vaccine.CONCLUSIONSThe study showed adequate immunity levels to tetanus amongst the Polish population, especially in children, adolescents, and young adults. However, those from older age groups should receive booster doses of the vaccine.
Author Śmietańska, Karolina
Rastawicki, Waldemar
Author_xml – sequence: 1
  givenname: Karolina
  orcidid: 0000-0002-7205-971X
  surname: Śmietańska
  fullname: Śmietańska, Karolina
– sequence: 2
  givenname: Waldemar
  orcidid: 0000-0002-3301-8632
  surname: Rastawicki
  fullname: Rastawicki, Waldemar
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39344719$$D View this record in MEDLINE/PubMed
BookMark eNo90EtLxDAQwPEgK-5Db54lRw_WzaOP9CiLrgsLCupNKNN0Uiptsiat6Le3uqunmcOPYfjPycQ6i4Scc3Yt0jiOlwDYLbkSucqOyIyrXEVCpHIy7kKKiOdpOiXzEN4YEypR_IRMZS7jOOP5jLw-oXc7jx_QotVInaGbek3B9k3pqgYDhRoaG3raYw92CLR3n66pKHTO1rRqjEGPth8Z0tq7YRdoY-mja8FWp-TYQBvw7DAX5OXu9nl1H20f1pvVzTbSQqV9JMBwk2bIWFZyQKUlaKZZgkrqvMx1BZKzpAKD2ugSQKACmas4rtI0S3QpF-Ryf3fn3fuAoS-6Jmhsxx_QDaGQnHPBhFBqpBcHOpQdVsXONx34r-KvyAiu9kB7F4JH8084K36DFz_Bi31w-Q1nknTc
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.26444/aaem/182987
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1898-2263
EndPage 333
ExternalDocumentID 39344719
10_26444_aaem_182987
Genre Journal Article
GeographicLocations Poland
GeographicLocations_xml – name: Poland
GroupedDBID ---
23M
2WC
53G
5GY
5VS
7RV
8FI
AAYXX
ABUWG
ADBBV
AENEX
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
CITATION
E3Z
EN8
F5P
FYUFA
GROUPED_DOAJ
HCIFZ
KQ8
M7P
NAPCQ
OK1
OVT
P2P
P6G
PIMPY
RNS
TR2
UKHRP
XSB
Y2W
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c286t-2af1f67e007b1ae8c3ac0c05e83c9b9cda3105dafecfcbaa2e8a39844d6675cb3
ISSN 1232-1966
1898-2263
IngestDate Fri Sep 05 06:15:59 EDT 2025
Mon Jul 21 05:40:42 EDT 2025
Tue Jul 01 02:59:14 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords IgG antibodies
tetanus
tetanus toxoid
vaccination
Language English
License https://creativecommons.org/licenses/by-nc/3.0/pl/deed.en
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c286t-2af1f67e007b1ae8c3ac0c05e83c9b9cda3105dafecfcbaa2e8a39844d6675cb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-3301-8632
0000-0002-7205-971X
OpenAccessLink https://www.aaem.pl/pdf-182987-104893?filename=Seroprevalence of IgG.pdf
PMID 39344719
PQID 3111202288
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_3111202288
pubmed_primary_39344719
crossref_primary_10_26444_aaem_182987
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-Sep-25
PublicationDateYYYYMMDD 2024-09-25
PublicationDate_xml – month: 09
  year: 2024
  text: 2024-Sep-25
  day: 25
PublicationDecade 2020
PublicationPlace Poland
PublicationPlace_xml – name: Poland
PublicationTitle Annals of Agricultural and Environmental Medicine
PublicationTitleAlternate Ann Agric Environ Med
PublicationYear 2024
SSID ssj0028581
Score 2.3591042
Snippet Vaccination is the most effective and reliable strategy for preventing the morbidity of tetanus. The aim of the study is to investigate the seroprevalence of...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
StartPage 329
SubjectTerms Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Antibodies, Bacterial - blood
Child
Child, Preschool
Female
Humans
Immunoglobulin G - blood
Infant
Male
Middle Aged
Poland - epidemiology
Seroepidemiologic Studies
Tetanus - epidemiology
Tetanus - immunology
Tetanus - prevention & control
Tetanus Toxoid - administration & dosage
Tetanus Toxoid - immunology
Vaccination - statistics & numerical data
Young Adult
Title Seroprevalence of IgG antibodies against tetanus toxoid among different age groups in Poland
URI https://www.ncbi.nlm.nih.gov/pubmed/39344719
https://www.proquest.com/docview/3111202288
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZB6UvY_dmNzRYnoLbWJYd-TGUbmVjY4OW9WHgSbIczBa7JA6U_vqdI8mXjBW2vRhjJxKc7_PROdK5EPKGwxJXKJEHSaLAQWEmDsDKnwfgGqQJNnaYccx3_vgpObvg7y_jy9Ho-yBqaduoI33zx7yS_0EVngGumCX7D8h2g8IDuAd84QoIw_WvMIYPHZuYwJD2-8SskOW7KciqVDVGB07lEhz_TTNtDNiAWyzmcF2Xue8w1PZGaaYYt2PTO2xw7Ofat_XorNa-yvJiue6LdeCe-2mfKOezfIcn9ZOTeJIuViVMj7eCb360KWi2WVB_ygRGKjZ1t7EFX-XP3KzkergjwTiGT7js5SPjtKhIASjmNZdXs17Zl0Mv3OrMyG15_K7L0VLjuFJJs8LtBcFStzQPgL1aWWSjFOsWetW7Wz27fXWH3GXgSGBzjw9funMmJmIRunQIO90xTnbspjog--2fd22WWxwRa5Cc3yf3vCdBF44WD8jIVA_JfovAI_Jtlx20Liiwg_bsoJ4d1LODOnZQyw7asQN-ZqhjBy0r6tjxmFy8PT0_OQt8L41AM5E0AZNFWCRzAyahCqUROpJ6pmexEZFOVapzCXZ-nMvC6EIrKZkRMkoF53kCLqVW0ROyV9WVOSQU0J3pmCtQ_RKMbS3DeVgonufzNInDuRyTSSut7MqVTMnA1bQCzlDAmRPwmLxuRZmBTsODKlmZervJIliAGRZmEmPy1Mm4G6nF5Nmtb56Tg56VL8hes96al2A5NuqVBf8XrDdxDw
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Seroprevalence+of+IgG+antibodies+against+tetanus+toxoid+among+different+age+groups+in+Poland&rft.jtitle=Annals+of+Agricultural+and+Environmental+Medicine&rft.au=%C5%9Amieta%C5%84ska%2C+Karolina&rft.au=Rastawicki%2C+Waldemar&rft.date=2024-09-25&rft.eissn=1898-2263&rft.volume=31&rft.issue=3&rft.spage=329&rft_id=info:doi/10.26444%2Faaem%2F182987&rft_id=info%3Apmid%2F39344719&rft.externalDocID=39344719
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1232-1966&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1232-1966&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1232-1966&client=summon